Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
McKinsey
Boehringer Ingelheim
Medtronic
Queensland Health
Fish and Richardson
Daiichi Sankyo
McKesson
Julphar
Cipla

Generated: August 18, 2017

DrugPatentWatch Database Preview

TIAGABINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Tiagabine Hydrochloride, and what generic Tiagabine Hydrochloride alternatives are available?

Tiagabine Hydrochloride is a drug marketed by Sun Pharm Inds and is included in one NDA.

The generic ingredient in TIAGABINE HYDROCHLORIDE is tiagabine hydrochloride. There are five drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the tiagabine hydrochloride profile page.

Summary for Tradename: TIAGABINE HYDROCHLORIDE

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list35
Clinical Trials: see list2,274
Patent Applications: see list314
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TIAGABINE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: TIAGABINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds
TIAGABINE HYDROCHLORIDE
tiagabine hydrochloride
TABLET;ORAL077555-001Nov 4, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds
TIAGABINE HYDROCHLORIDE
tiagabine hydrochloride
TABLET;ORAL077555-002Nov 4, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Federal Trade Commission
Citi
Cipla
Fuji
Baxter
McKinsey
Deloitte
Covington
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot